Award type :
Product Development Award
Product Development Award
Product type :
Vaccines
Vaccines
Award year :
2020
2020
Project start date :
07 / 03 / 2020
07 / 03 / 2020
Project end date :
04 / 30 / 2021
04 / 30 / 2021
Project duration (months) :
9
9
Development stage :
Preclinical
Preclinical
Target disease :
Tuberculosis
Tuberculosis
Region served :
World
World
Recipient organization / Country of funding recipient organization :
Raphas / Republic of Korea
Raphas / Republic of Korea
Collaborator(s) / Country :
Seoul National University (SNU) / Republic of Korea
Seoul National University (SNU) / Republic of Korea
Funding amount(KRW) :
400,000,000
400,000,000
This project by Raphas and Seoul National University aims to develop a Mycobacterium paragordonae (Mpg) Microarray Patch tuberculosis (TB) vaccine with improved safety and efficacy over BCG. The project explores the potential of Mpg to replace BCG as a preventive and therapeutic vaccine.